Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort
Open Access
- 1 January 2013
- journal article
- Published by Springer Science and Business Media LLC in Arthritis Research & Therapy
- Vol. 15 (6), R210
- https://doi.org/10.1186/ar4404
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Role of Adipokines in Atherosclerosis: Interferences with Cardiovascular Complications in Rheumatic DiseasesMediators of Inflammation, 2012
- Total and High-Molecular-Weight Adiponectin and Resistin in Relation to the Risk for Type 2 Diabetes in WomenAnnals of Internal Medicine, 2008
- Adipokines as emerging mediators of immune response and inflammationNature Clinical Practice Rheumatology, 2007
- Adipocytokines: mediators linking adipose tissue, inflammation and immunityNature Reviews Immunology, 2006
- Recent advances in the relationship between obesity, inflammation, and insulin resistance.2006
- Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritisArthritis Research & Therapy, 2005
- Prognostic laboratory markers of joint damage in rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2005
- Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP)Annals Of The Rheumatic Diseases, 2004
- Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three-year prospective study in community-recruited patientsRheumatology, 2003
- Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategiesAmerican Journal Of Medicine, 2001